10+
Downloads
Content rating
Everyone
Screenshot image
Screenshot image
Screenshot image

About this app

Oncobeta GmbH has developed a treatment for Non-Melanoma skin cancer (NMSC) called
Rhenium-SCT. Oncobeta is committed to continually improving patient outcomes and
therefore is sponsoring an international registry.

You are being invited to participate in a registry for patients being treated for non-melanoma skin cancer (NMSC). This study is called a ‘registry’. This means that information will be collected and stored to answer scientific questions about people with the same condition or disease, and who receive treatment for NMSC. You are invited to participate in this Registry because you have undergone or about to undergo treatment for NMSC. This consent form provides you with information to help you make an informed choice. Please read this document carefully and take your time in making your decision. You may find it helpful to discuss it with your friends and family.
Updated on
Jul 5, 2024

Data safety

Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.
No data shared with third parties
Learn more about how developers declare sharing
No data collected
Learn more about how developers declare collection

What’s new

Update to support Android API 13

App support

About the developer
UNIVERSITY OF MELBOURNE
rsinnott@unimelb.edu.au
Grattan St Parkville VIC 3010 Australia
+61 435 964 844

More by Melbourne eResearch Group Unimelb